Justin Taylor
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Justin Taylor
May 17, 2024, 01:19 |
Blog
Justin Taylor: Peter Aplan discussing Preclinical Models of MDSsm
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared on X/Twitter: “Second…
May 12, 2024, 01:40 |
Insight
Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen
Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…
Mar 3, 2024, 17:55 |
Blog
Meet Dr. Justin Taylor and Skye Montoya, a dynamic mentor-mentee duo - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center posted on LinkedIn: "Meet Dr. Justin Taylor and Skye Montoya, a…
Jan 13, 2024, 15:53 |
Blog
Justin Taylor: Thrilled to have been part of this work from Tothova Lab
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared on X/Twitter: "Thrilled…
Oct 10, 2023, 21:35 |
Opinion
Justin Taylor: We show that E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies.
Justin Taylor, Assistant Professor at UM Sylvester Comprehensive Cancer Center and Principle Investigator at the…
All:
5
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube